Mapping the binding site on small ankyrin 1 for obscurin
- PMID: 17720975
- DOI: 10.1074/jbc.M704089200
Mapping the binding site on small ankyrin 1 for obscurin
Abstract
Small ankyrin 1 (sAnk1), an integral protein of the sarcoplasmic reticulum encoded by the ANK1 gene, binds with nanomolar affinity to the C terminus of obscurin, a giant protein surrounding the contractile apparatus in striated muscle. We used site-directed mutagenesis to characterize the binding site on sAnk1, specifically addressing the role of two putative amphipathic, positively charged helices. We measured binding qualitatively by blot overlay assays and quantitatively by surface plasmon resonance and showed that both positively charged sequences are required for activity. We showed further that substitution of a lysine or arginine with an alanine or glutamate located at the same position along either of the two putative helices has similar inhibitory or stimulatory effects on binding and that the effects of a particular mutation depended on the position of the mutated amino acid in each helix. We modeled the structure of the binding region of sAnk1 by homology with ankyrin repeats of human Notch1, which have a similar pattern of charged and hydrophobic residues. Our modeling suggested that each of the two positively charged sequences forms pairs of amphipathic, anti-parallel alpha-helices flanked by beta-hairpin-like turns. Most of the residues in homologous positions along each helical unit have similar, though not identical, orientations. CD spectroscopy confirmed the alpha-helical content of sAnk1, approximately 33%, predicted by the model. Thus, structural and mutational studies of the binding region on sAnk1 for obscurin suggest that it consists of two ankyrin repeats with very similar structures.
Similar articles
-
Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies.J Mol Biol. 2011 Apr 29;408(2):321-34. doi: 10.1016/j.jmb.2011.01.053. Epub 2011 Feb 17. J Mol Biol. 2011. PMID: 21333652 Free PMC article.
-
Hydrophobic residues in small ankyrin 1 participate in binding to obscurin.Mol Membr Biol. 2012 Mar;29(2):36-51. doi: 10.3109/09687688.2012.660709. Mol Membr Biol. 2012. PMID: 22416964 Free PMC article.
-
Obscurin is a ligand for small ankyrin 1 in skeletal muscle.Mol Biol Cell. 2003 Mar;14(3):1138-48. doi: 10.1091/mbc.e02-07-0411. Mol Biol Cell. 2003. PMID: 12631729 Free PMC article.
-
Obscurin: a multitasking muscle giant.J Muscle Res Cell Motil. 2005;26(6-8):419-26. doi: 10.1007/s10974-005-9024-7. J Muscle Res Cell Motil. 2005. PMID: 16625317 Review.
-
Obscurins: unassuming giants enter the spotlight.IUBMB Life. 2013 Jun;65(6):479-86. doi: 10.1002/iub.1157. Epub 2013 Mar 20. IUBMB Life. 2013. PMID: 23512348 Free PMC article. Review.
Cited by
-
Cardiac ankyrins in health and disease.J Mol Cell Cardiol. 2009 Aug;47(2):203-9. doi: 10.1016/j.yjmcc.2009.04.010. Epub 2009 Apr 24. J Mol Cell Cardiol. 2009. PMID: 19394342 Free PMC article. Review.
-
Obscurin is a semi-flexible molecule in solution.Protein Sci. 2019 Apr;28(4):717-726. doi: 10.1002/pro.3578. Epub 2019 Feb 6. Protein Sci. 2019. PMID: 30666746 Free PMC article.
-
Structure of giant muscle proteins.Front Physiol. 2013 Dec 12;4:368. doi: 10.3389/fphys.2013.00368. Front Physiol. 2013. PMID: 24376425 Free PMC article. Review.
-
Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover.Mol Biol Cell. 2012 Jul;23(13):2490-504. doi: 10.1091/mbc.E12-01-0052. Epub 2012 May 9. Mol Biol Cell. 2012. PMID: 22573887 Free PMC article.
-
The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.Mol Biol Cell. 2009 Sep;20(17):3905-17. doi: 10.1091/mbc.e08-10-1029. Epub 2009 Jul 15. Mol Biol Cell. 2009. PMID: 19605563 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources